Schug SA, Lavand’homme P, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain. 2019;160(1):45–52.

PubMed  Google Scholar 

Duale C, Ouchchane L, Schoeffler P, Group EI, Dubray C. Neuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-up. J Pain. 2014;15(1):24.e1-e0.

PubMed  Google Scholar 

Fletcher D, Stamer UM, Pogatzki-Zahn E, et al. Chronic postsurgical pain in Europe: an observational study. Eur J Anaesthesiol. 2015;32(10):725–34.

PubMed  Google Scholar 

Haroutiunian S, Nikolajsen L, Finnerup NB, Jensen TS. The neuropathic component in persistent postsurgical pain: a systematic literature review. Pain. 2013;154(1):95–102.

PubMed  Google Scholar 

Simanski CJ, Althaus A, Hoederath S, et al. Incidence of chronic postsurgical pain (CPSP) after general surgery. Pain Med. 2014;15(7):1222–9.

PubMed  Google Scholar 

Cregg R, Anwar S, Farquhar-Smith P. Persistent postsurgical pain. Curr Opin Support Palliat Care. 2013;7(2):144–52.

PubMed  Google Scholar 

Schug SA, Bruce J. Risk stratification for the development of chronic postsurgical pain. Pain Rep. 2017;2(6): e627.

PubMed  PubMed Central  Google Scholar 

Browne AL, Andrews R, Schug SA, Wood F. Persistent pain outcomes and patient satisfaction with pain management after burn injury. Clin J Pain. 2011;27(2):136–45.

PubMed  Google Scholar 

Gross T, Amsler F. Prevalence and incidence of longer term pain in survivors of polytrauma. Surgery. 2011;150(5):985–95.

PubMed  Google Scholar 

Zhou Y, Liu P, Rui J, Zhao X, Lao J. The clinical characteristics of neuropathic pain in patients with total brachial plexus avulsion: a 30-case study. Injury. 2016;47(8):1719–24.

PubMed  Google Scholar 

Miclescu A, Straatmann A, Gkatziani P, Butler S, Karlsten R, Gordh T. Chronic neuropathic pain after traumatic peripheral nerve injuries in the upper extremity: prevalence, demographic and surgical determinants, impact on health and on pain medication. Scand J Pain. 2019;20(1):95–108.

PubMed  Google Scholar 

Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.

CAS  PubMed  PubMed Central  Google Scholar 

Dahlin LB, Wiberg M. Nerve injuries of the upper extremity and hand. EFORT Open Rev. 2017;2(5):158–70.

PubMed  PubMed Central  Google Scholar 

Attal N, Lanteri-Minet M, Laurent B, Fermanian J, Bouhassira D. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain. 2011;152(12):2836–43.

PubMed  Google Scholar 

Peng Z, Li H, Zhang C, Qian X, Feng Z, Zhu S. A retrospective study of chronic post-surgical pain following thoracic surgery: prevalence, risk factors, incidence of neuropathic component, and impact on qualify of life. PLoS ONE. 2014;9(2): e90014.

PubMed  PubMed Central  Google Scholar 

Steyaert A, Lavand’homme P. Acute and chronic neuropathic pain after surgery: still a lot to learn. Eur J Anaesthesiol. 2017;34(10):650–1.

PubMed  Google Scholar 

Langley PC, Van Litsenburg C, Cappelleri JC, Carroll D. The burden associated with neuropathic pain in Western Europe. J Med Econ. 2013;16(1):85–95.

PubMed  Google Scholar 

Schaefer C, Sadosky A, Mann R, et al. Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study. Clinicoecon Outcomes Res. 2014;6:483–96.

PubMed  PubMed Central  Google Scholar 

Allen C, Walker AM, Premji ZA, et al. Preventing persistent postsurgical pain: a systematic review and component network meta-analysis. Eur J Pain. 2022;26(4):771–85.

PubMed  Google Scholar 

Darzi SA, Munz Y. The impact of minimally invasive surgical techniques. Annu Rev Med. 2004;55:223–37.

CAS  PubMed  Google Scholar 

Bannister K, Sachau J, Baron R, Dickenson AH. Neuropathic pain: mechanism-based therapeutics. Annu Rev Pharmacol Toxicol. 2020;60:257–74.

CAS  PubMed  Google Scholar 

Schlereth T, et al. Diagnosis and non-interventional therapy of neuropathic pain [Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen]; S2k-level guideline of the Deutsche Gesellschaft für Neurologie; Guidelines for Diagnostics and Therapy in Neurology. 2019. https://www.dgn.org/leitlinien. Accessed 13 Nov 2019

Soliman N, Moisset X, Ferraro MC, et al. Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis. Lancet Neurol. 2025;24(5):413–28.

CAS  PubMed  Google Scholar 

Schubert T, Kern KU, Schneider S, Baron R. Oral or topical pain therapy—how would patients decide? A discrete choice experiment in patients with peripheral neuropathic pain (pNP). Pain Pract. 2021;21(5):536–46.

PubMed  Google Scholar 

Freynhagen R, Argoff C, Eerdekens M, Engelen S, Perrot S. Progressive response to repeat application of capsaicin 179 mg (8% w/w) cutaneous patch in peripheral neuropathic pain: comprehensive new analysis and clinical implications. Pain Med. 2021;22(10):2324–36.

PubMed  PubMed Central  Google Scholar 

Galvez R, Navez ML, Moyle G, et al. Capsaicin 8% patch repeat treatment in nondiabetic peripheral neuropathic pain: a 52-week, open-label, single-arm, safety study. Clin J Pain. 2017;33(10):921–31.

PubMed  Google Scholar 

Goncalves D, Rebelo V, Barbosa P, Gomes A. 8% capsaicin patch in treatment of peripheral neuropathic pain. Pain Physician. 2020;23(5):E541–8.

PubMed  Google Scholar 

Hansson P, Jensen TS, Kvarstein G, Stromberg M. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice. Eur J Pain. 2018;22(5):941–50.

CAS  PubMed  PubMed Central  Google Scholar 

Maihöfner C, Heskamp ML. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study. Curr Med Res Opin. 2013;29(6):673–83.

PubMed  Google Scholar 

Mankowski C, Poole CD, Ernault E, et al. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study. BMC Neurol. 2017;17(1):80.

PubMed  PubMed Central  Google Scholar 

Tenreiro Pinto J, Pereira FC, Loureiro MC, Gama R, Fernandes HL. Efficacy analysis of capsaicin 8% patch in neuropathic peripheral pain treatment. Pharmacology. 2018;101(5–6):290–7.

CAS  PubMed  Google Scholar 

Vieira IF, de Castro AM, Loureiro MDC, Pinto J, Cardoso C, Assuncao JP. Capsaicin 8% for peripheral neuropathic pain treatment: a retrospective cohort study. Pain Physician. 2022;25(4):E641–7.

PubMed  Google Scholar 

Vinik AI, Perrot S, Vinik EJ, et al. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC Neurol. 2016;16(1):251.

PubMed  PubMed Central  Google Scholar 

Vinik AI, Perrot S, Vinik EJ, et al. Repeat treatment with capsaicin 8% patch (179 mg capsaicin cutaneous patch): effects on pain, quality of life, and patient satisfaction in painful diabetic peripheral neuropathy: an open-label, randomized controlled clinical trial. Curr Med Res Opin. 2019;2:388–401.

Google Scholar 

Lux MP, Flother L, Fromter C, et al. Topical treatment of chemotherapy-induced peripheral neuropathy (CIPN) with high-concentration (179 mg) capsaicin patch in breast cancer patients – results of the QUCIP study. Front Oncol. 2024;14:1452099.

PubMed  PubMed Central  Google Scholar 

Haanpää M, Cruccu G, Nurmikko TJ, et al. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain. Eur J Pain. 2016;20(2):316–28.

PubMed  Google Scholar 

SmPC. European Medicines Agency (EMA). Qutenza 179 mg cutaneous patch: EU summary of product characteristics. 2024. https://www.ema.europa.eu/en/documents/product-information/qutenza-epar-product-information_en.pdf. Accessed 5 Dec 2024.

FDA. U. S. Food and Rug Administration; Approval Letter Qutenza. 2010. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022395s000Approv.pdf. Accessed 7 Apr 2024

Bischoff JM, Ringsted TK, Petersen M, Sommer C, Uceyler N, Werner MU. A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial. PLoS ONE. 2014;9(10): e109144.

PubMed  PubMed Central  Google Scholar 

Mullins CF, Walsh S, Rooney A, McCrory C, Das B. A preliminary prospective observational study of the effectiveness of high-concentration capsaicin cutaneous patch in the management of chronic post-surgical neuropathic pain. Ir J Med Sci. 2022;191(2):859–64.

CAS  PubMed  Google Scholar 

Santos MP, Lemos F, Gomes J, Romão JM, Veiga D. Topical capsaicin 8% patch in peripheral neuropathic pain: efficacy and quality of life. Br J Pain. 2024;18(1):42–56.

PubMed  Google Scholar 

Zis P, Bernali N, Argira E, Siafaka I, Vadalouka A. Effectiveness and impact of capsaicin 8% patch on quality of life in patients with lumbosacral pain: an open-label study. Pain Physician. 2016;19(7):E1049–53.

PubMed  Google Scholar 

Dupoiron D, Bienfait F, Seegers V, et al. Evaluating treatment preferences and the efficacy of capsaicin 179 mg patch vs. pregabalin in a randomized trial for postsurgical neuropathic pain in breast cancer: CAPTRANE. Cancers (Basel). 2025;17(2):313.

CAS